Updated Jul 16, 2026 · Last SEC filing 2026-07-07
uniQure N.V. (QURE) has filed 20 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 7 Form 8-K material event filings were reported by QURE in the last 90 days. 22 Form 144 notices of proposed sale were filed for QURE stock. InsiderAlpha tracks every QURE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001590560 |
|---|
| Form 4 filings (90d) | 20 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Form 144 notices (90d) | 22 |
| Latest Form 4 filing | 2026-07-07 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kapusta Matthew C | CEO, Managing Director | S — Open-market sale | 7.6K | $45.89 | $349K | SEC | |
| Kapusta Matthew C | CEO, Managing Director | M — Option exercise | 21.1K | $19.39 | $409K | SEC | |
| Kapusta Matthew C | CEO, Managing Director | S — Open-market sale | 9.2K | $44.43 | $409K | SEC | |
| Kapusta Matthew C | CEO, Managing Director | S — Open-market sale | 4.3K | $45.43 | $195K | SEC | |
| Abi-Saab Walid | Chief Medical Officer | S — Open-market sale | 10.0K | $46.46 | $465K | SEC | |
| Abi-Saab Walid | Chief Medical Officer | M — Option exercise | 10.0K | $5.59 | $56K | SEC | |
| Kaye Jack | Director | M — Option exercise | 4.1K | $37.00 | $152K | SEC | |
| Kaye Jack | Director | S — Open-market sale | 17.1K | $46.43 | $792K | SEC | |
| Abi-Saab Walid | Chief Medical Officer | S — Open-market sale | 20.0K | $46.40 | $928K | SEC | |
| Kaye Jack | Director | M — Option exercise | 17.1K | $20.18 | $344K | SEC | |
| Kaye Jack | Director | S — Open-market sale | 4.1K | $46.49 | $191K | SEC | |
| Abi-Saab Walid | Chief Medical Officer | S — Open-market sale | 1.4K | $46.86 | $67K | SEC | |
| Kapusta Matthew C | CEO, Managing Director | M — Option exercise | 28.7K | $31.71 | $911K | SEC | |
| Kapusta Matthew C | CEO, Managing Director | S — Open-market sale | 28.7K | $50.02 | $1.44M | SEC | |
| Kapusta Matthew C | CEO, Managing Director | S — Open-market sale | 6.7K | $50.00 | $335K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for uniQure N.V. (QURE). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Kapusta Matthew C | 23 | $14.91M |
| Kaye Jack | 15 | $2.05M |
| Balachandran Madhavan | 13 | $1.24M |
| Abi-Saab Walid | 9 | $2.78M |
| Gut Robert | 8 | $313K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in QURE insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live QURE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.